Cargando…
T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis
Humoral and cellular responses are critical in understanding immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Here, we evaluated these responses in hemodialysis (HD) patients after the booster vaccination. SARS-CoV-2 immunoglobulin (IgG) levels, neutraliz...
Autores principales: | Yoshifuji, Ayumi, Toda, Masataro, Ryuzaki, Munekazu, Oyama, Emi, Kikuchi, Kan, Kawai, Toru, Sakai, Ken, Koinuma, Masayoshi, Katayama, Kazuhiko, Yokoyama, Takashi, Uehara, Yuki, Ohmagari, Norio, Kanno, Yoshihiko, Kon, Hirofumi, Shinoda, Toshio, Takano, Yaoko, Tanaka, Junko, Hora, Kazuhiko, Nakazawa, Yasushi, Hasegawa, Naoki, Hanafusa, Norio, Hinoshita, Fumihiko, Morikane, Keita, Wakino, Shu, Nakamoto, Hidetomo, Takemoto, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057502/ https://www.ncbi.nlm.nih.gov/pubmed/36992238 http://dx.doi.org/10.3390/vaccines11030653 |
Ejemplares similares
-
Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis
por: Yoshifuji, Ayumi, et al.
Publicado: (2022) -
Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy
por: Yoshifuji, Ayumi, et al.
Publicado: (2022) -
Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022) -
Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022) -
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients
por: Toda, Masataro, et al.
Publicado: (2021)